Niall Horan can’t live without us…
Preview text: Just ask GQ
Image not available
No image available for this email.
- Subject
- Niall Horan can’t live without us…
- Preview text
- Just ask GQ
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Wed Jul 1, 2026, 6:01 AM ET
- Size
- 50 KB
- Images
- 12
- Links
- 14, 2 of them buttons
- Subject length
- 35 characters
Against Salt Grooming's usual
Sent in the 6 AM hour, which holds 16% of its emails; 19% arrive in the 5 AM hour. The subject is 35 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- SALT <[email protected]>
- Subject
- Niall Horan can’t live without us…
- Date
- Wed, 01 Jul 2026 10:01:02 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-58
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from o1375.shared.klaviyomail.com [149.72.197.103] by our receiving server with ESMTPS
- by recvd-…-wxfk2 with SMTP
- from (unnamed) by geopod-ismtpd-58 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| Jul 6, 2026 4:30 AM | Heat’s not the problem | |
| Jul 4, 2026 5:00 AM | Barber noticed your thinning? | |
| Jul 2, 2026 6:30 AM | Is the fade dead? | |
| Jul 1, 2026 6:01 AM | Niall Horan can’t live without us… (this email) | |
| Jun 30, 2026 4:00 AM | Select your payday gift | |
| Jun 29, 2026 11:14 PM | Selling Fast - Secure your product | |
| Jun 29, 2026 4:00 AM | Celebrate payday with a free gift |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM
